Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Newly Approved and Promising Antidiabetic Agents

Murielle Combettes, Catherine Kargar

Thérapie, 62 4 (2007) 293-310

Publié en ligne : 2007-11-06

DOI: https://doi.org/10.2515/therapie:2007054

Citations de cet article :

Incretins: Beyond type 2 diabetes

Paresh Dandona, Husam Ghanim and Ajay Chaudhuri
Diabetes, Obesity and Metabolism 20 (S1) 59 (2018)
https://doi.org/10.1111/dom.13153

Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou, et al.
European Journal of Medicinal Chemistry 108 444 (2016)
https://doi.org/10.1016/j.ejmech.2015.12.004

Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats

Ajaykumar N. Sharma, Ashish Pise, Jay N. Sharma and Praveen Shukla
Metabolic Brain Disease 30 (3) 659 (2015)
https://doi.org/10.1007/s11011-014-9603-7

Scully's Medical Problems in Dentistry

Crispian Scully
Scully's Medical Problems in Dentistry 171 (2014)
https://doi.org/10.1016/B978-0-7020-5401-3.00006-0

Energy loss via urine and faeces – a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight

R. Elvert, A. Wille, J. Wandschneider, U. Werner, H. Glombik and A. W. Herling
Diabetes, Obesity and Metabolism 15 (4) 324 (2013)
https://doi.org/10.1111/dom.12030

Prunus yedoensisMatsum. stimulates glucose uptake in L6 rat skeletal muscle cells by activating AMP-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways

Keanae Jo, Seung-Eun Lee, Sang-Won Lee and Jae-Kwan Hwang
Natural Product Research 26 (17) 1610 (2012)
https://doi.org/10.1080/14786419.2011.574133

Chiara Falciani, Alessandro Pini and Luisa Bracci
247 (2011)
https://doi.org/10.1002/9783527631827.ch7

Ceramide formation as a target in beta-cell survival and function

Florian Lang, Susanne Ullrich and Erich Gulbins
Expert Opinion on Therapeutic Targets 15 (9) 1061 (2011)
https://doi.org/10.1517/14728222.2011.588209

Personality, a key factor in personalized medicine?

Gretha J. Boersma, Lambertus Benthem, Andre P. van Beek, Gertjan van Dijk and Anton J.W. Scheurink
European Journal of Pharmacology 667 (1-3) 23 (2011)
https://doi.org/10.1016/j.ejphar.2011.05.079

Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes

Carmen Castaneda-Sceppa and Francisco Castaneda
Nutrition Reviews 69 (12) 720 (2011)
https://doi.org/10.1111/j.1753-4887.2011.00423.x

Pdx-1 Regulation of the INGAP Promoter Involves Sequestration of NeuroD Into a Non-DNA-Binding Complex

David A. Taylor-Fishwick, Wenjing Shi, Laura Hughes and Aaron Vinik
Pancreas 39 (1) 64 (2010)
https://doi.org/10.1097/MPA.0b013e3181baa0cc

Hepatic electrical stimulation reduces blood glucose in diabetic rats

J. Chen, P. J. Pasricha, J. Yin, L. Lin and J. D. Z. Chen
Neurogastroenterology & Motility 22 (10) 1109 (2010)
https://doi.org/10.1111/j.1365-2982.2010.01556.x

Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition

Ken Abe, Lydia Kuo and Zofia Zukowska
Experimental Biology and Medicine 235 (10) 1179 (2010)
https://doi.org/10.1258/ebm.2010.009136

Sphingomyelinase dependent apoptosis following treatment of pancreatic beta-cells with amyloid peptides Aß1-42 or IAPP

Ying Zhang, Felicia Ranta, Cai Tang, et al.
Apoptosis 14 (7) 878 (2009)
https://doi.org/10.1007/s10495-009-0364-4

New Therapeutic Agents for Diabetes Mellitus: Implications for Anesthetic Management

Daniel Chen, Stephanie L. Lee and Robert A. Peterfreund
Anesthesia & Analgesia 108 (6) 1803 (2009)
https://doi.org/10.1213/ane.0b013e31819dcc51

An update on preventive and regenerative therapies in diabetes mellitus

M. Reimann, E. Bonifacio, M. Solimena, et al.
Pharmacology & Therapeutics 121 (3) 317 (2009)
https://doi.org/10.1016/j.pharmthera.2008.11.009

Beyond insulin replacement: addressing the additional needs of the diabetes patient

G. Dailey
Diabetes, Obesity and Metabolism 10 (s2) 83 (2008)
https://doi.org/10.1111/j.1463-1326.2008.00847.x

Drug interactions

C. Scully
British Dental Journal 204 (1) 4 (2008)
https://doi.org/10.1038/bdj.2007.1196

Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?

Martin C. Michel, Eric Fliers and Cornelis J. F. Van Noorden
Naunyn-Schmiedeberg's Archives of Pharmacology 377 (3) 205 (2008)
https://doi.org/10.1007/s00210-008-0280-0